Lab Information

Peter Lakatos (MD)

Investigator
Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 50%
 Epidemiology: 0%
 Evaluation: 50%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Inflammatory bowel diseases (IBD) • gastroenterology • colitis • Crohn’s disease

Team Members

Name Position

Latest Publications

  1. Wetwittayakhlang, P., Ngampech, S., Pattarakulniyom, S. & Lakatos, P. L. (2025). Objective Treatment Targets and Their Correlation with Patient-Reported Outcomes in Inflammatory Bowel Disease: A Real-World Study. Journal of clinical medicine, vol. 14.
  2. De Marco, D., Heron, V., Bitton, A., Bessissow, T., Lakatos, P., Wild, G. & Afif, W. (2025). Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study. Journal of the Canadian Association of Gastroenterology, vol. 8, p. 97-102.
  3. Wewer, M. D., Lophaven, S., Lakatos, P. L., Gonczi, L., Salupere, R., Kievit, H. A. L., Nielsen, K. R., Midjord, J., Domislovic, V., Krznarić, Ž., Pedersen, N., Kjeldsen, J., Halfvarson, J., Sebastian, S., Goldis, A., Arebi, N., Oksanen, P., Neumann, A., Andersen, V., Katsanos, K. H., Koukoudis, A., Turcan, S., Ellul, P., Kupcinskas, J., Kiudelis, G., Fumery, M., Kaimakliotis, I. P., D'Inca, R., Lombardini, S., Hernandez, V., Fernandez, A., Langholz, E., Munkholm, P., Burisch, J. & Epi-IBD-group (2025). Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort - an Epi-IBD cohort study. Journal of Crohn's & colitis, vol. 19.
  4. Hanžel, J., Solitano, V., Vuyyuru, S. K., Panaccione, R., Sands, B. E., Peyrin-Biroulet, L., Danese, S., D'Haens, G. R., Atreya, R., Allez, M., Bernstein, C. N., Bossuyt, P., Bressler, B., Bryant, R. V., Cohen, B. L., Colombel, J.-F., D'Amico, F., Dignass, A., Dubinsky, M., Fleshner, P., Gearry, R. B., Hanauer, S. B., Hart, A. L., Kayal, M., Kucharzik, T., Lakatos, P. L., Louis, E., Magro, F., Narula, N., Leong, R. W., Panés, J., Raine, T., Ran, Z., Regueiro, M. D., Reinisch, W., Singh, S., Steinhart, A. H., Travis, S., Ungaro, R. C., Janneke van der Woude, C., Yamamoto, T., Ahuja, V., Rubin, D. T., Dulai, P. S., Cornfield, L. J., Hogan, M., Sandborn, W. J., Feagan, B. G., Jairath, V. & Ma, C. (2025). An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Gastroenterology.
  5. Farkas, B., Limdi, J. K., Bacsur, P., Savarino, E. V., Bertin, L., Sethi-Arora, K., Miheller, P., Vilmos, F., Castiglione, F., Bonacci, L., Lukas, M., Maharshak, N., Berman, G., Krznaric, Ž., Wetwittayakhlang, P., Lakatos, P. L., Seidelin, J. B., Attauabi, M., Michalopoulos, G., Ribaldone, D. G., Kagramanova, A., Chashkova, E., Sarlós, P., Saibeni, S., Shitrit, A.-B., Borsos, M., Resál, T., Szepes, Z., Molnár, T. & Farkas, K. (2025). Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study. Expert opinion on biological therapy, p. 1-10.
  6. Hracs, L., Windsor, J. W., Gorospe, J., Cummings, M., Coward, S., Buie, M. J., Quan, J., Goddard, Q., Caplan, L., Markovinović, A., Williamson, T., Abbey, Y., Abdullah, M., Abreu, M. T., Ahuja, V., Raja Ali, R. A., Altuwaijri, M., Balderramo, D., Banerjee, R., Benchimol, E. I., Bernstein, C. N., Brunet-Mas, E., Burisch, J., Chong, V. H., Dotan, I., Dutta, U., El Ouali, S., Forbes, A., Forss, A., Gearry, R., Dao, V. H., Hartono, J. L., Hilmi, I., Hodges, P., Jones, G.-R., Juliao-Baños, F., Kaibullayeva, J., Kelly, P., Kobayashi, T., Kotze, P. G., Lakatos, P. L., Lees, C. W., Limsrivilai, J., Lo, B., Loftus, E. V., Ludvigsson, J. F., Mak, J. W. Y., Miao, Y., Ng, K. K., Okabayashi, S., Olén, O., Panaccione, R., Paudel, M. S., Quaresma, A. B., Rubin, D. T., Simadibrata, M., Sun, Y., Suzuki, H., Toro, M., Turner, D., Iade, B., Wei, S. C., Yamamoto-Furusho, J. K., Yang, S.-K., Ng, S. C., Kaplan, G. G. & Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group (2025). Global evolution of inflammatory bowel disease across epidemiologic stages. Nature, vol. 642, p. 458-466.
  7. Angyal, D., Balogh, F., Bessissow, T., Wetwittayakhlang, P., Ilias, A., Gonczi, L. & Lakatos, P. L. (2025). The Role of Histology Alongside Clinical and Endoscopic Evaluation in the Management of IBD-A Narrative Review. Journal of clinical medicine, vol. 14.
  8. Candel, I., Wetwittayakhlang, P., Bessissow, T. & Lakatos, P. L. (2025). The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases. Journal of clinical medicine, vol. 14.
  9. Balogh, F., Angyal, D., Ecseki, A. Á., Sebeszta, Z. V., Gönczi, L., Lontai, L., Miheller, P., Lakatos, P. & Iliás, Á. (2025). [Anemia classification, prevalence and predictive factors in inflammatory bowel disease]. Orvosi hetilap, vol. 166, p. 60-66.
  10. Farkas, B., Bessissow, T., Limdi, J. K., Sethi-Arora, K., Kagramanova, A., Knyazev, O., Bezzio, C., Armuzzi, A., Lukas, M., Michalopoulos, G., Chaskova, E., Savarino, E. V., Castiglione, F., Rispo, A., Schäfer, E., Saibeni, S., Filip, R., Attauabi, M., Fousekis, F. S., Bacsur, P., Resál, T., Bálint, A., Ivány, E., Szepes, Z., Bősze, Z., Fábián, A., Bor, R., Farkas, K., Lakatos, P. L. & Molnár, T. (2024). Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study. Journal of clinical medicine, vol. 13.
More on PubMed 



See also

Card image
Talat
Bessissow


See profile
Card image
Waqqas
Afif


See profile
Card image
Alain
Bitton


See profile
Card image
Paul
Brassard


See profile
Card image
Matthieu
Allez


See profile
Card image
Bertrand
Lebouché


See profile